Deka Cynosure SmartXide2 MonaLisa Touch Sale

For sale  Deka Cynosure SmartXide2 MonaLisa Touch Sale with affordable price USD $ 12000 .00. Please contact us for ordering information. All prices are subject to change without notice, except that prices for an order that have been accepted.

Deka Cynosure SmartXide2 MonaLisa Touch

The Deka Cynosure SmartXide 2 MonaLisa Touch is a state-of-the-art fractional CO? laser system—developed by DEKA (Italy) and marketed by Cynosure—designed specifically for gynecologic and aesthetic soft-tissue applications. Here's a comprehensive overview:

Technology & Device Highlights

• Laser Type & Wavelength
  Utilizes a fractional CO? laser with a 10.6 μm wavelength, employing Dermis-mode Energy Fractionation via proprietary Pulse Shape Design (PSD) technology—most notably the D-Pulse—tailored for vaginal mucosal treatments.

• SmartXide 2 Platform
  Incorporates CO? RF laser source with PSD pulses and optional emission modes (S-, D-, H-, U-Pulse, CW). Features versatility via internal/external handpieces (V2LR, VLR) and Hi-Scan V²LR scanning system for precise, repeatable delivery.

• Fractional Delivery
  Laser beam delivered in microscopic dots (“DOT therapy”), spaced ~200 μm apart, penetrating surface and connective tissue to stimulate collagen, angiogenesis, mucosal regeneration with minimal collateral damage.

Indications & Clinical Benefits

• Vulvo-Vaginal Rejuvenation (V2LR)
  Addresses vaginal atrophy, laxity, dryness, painful intercourse, urinary stress incontinence, perineal trauma, and postmenopausal/genital morphological concerns.

• Broader Soft-Tissue Use
  Beyond gynecology, indicated for incision, ablation, coagulation of soft tissues—suitable for ENT, dermatology, podiatry, urology, dental/oral, neurosurgery, thoracic, and general plastic surgery.

• Clinical Evidence
  Over 80 peer-reviewed studies support its efficacy and safety; histological analyses show restored mucosa to pre-menopausal quality (thicker epithelium, collagen-rich connective tissue)

Summary

• Proven fractional CO? technology tailored for vaginal rejuvenation and soft-tissue applications

• Ease of use, rapid treatments, high patient satisfaction (~97%)

• Clinically validated, versatile, minimal downtime

• Built for safety: precision dosing, ergonomic design, robust contraindication screening

This comprehensive, medically validated platform enables gynecologists and specialists to deliver safe, effective interventions for women’s intimate health and beyond, with powerful technology and strong clinical backing.